Research group for molecular biology and nanomedicine

The research activities of the Molecular Biology and Nanomedicine have multidisciplinary foundations, deriving their potency from the combination of synthetic chemistry, biochemistry, nanotechnology, medicine, molecular and cellular biology plus immunology. In the sense of specific focus the group is further divided into Lab for nanomedicine, Lab for molecular biology and Lab for microbiology.

Výzkumná skupina molekulární biologie a nanomedicíny

The essential working philosophy resides in the identification of molecular mechanisms that are responsible for the development of oncological diseases (in particular prostate tumour, breast tumour and neurobastoms), their seriousness or the origin of chemo-resistance, with the following design and testing of functional nanoscopic modalities in vitro and in vivo. In the same way also bacterial infections are studied, and namely with primary focus upon resistant/multi-resistant bacterial stems occurring both in human and in veterinary medicine. Special highlight is reserved to the understanding of the fate of nanomaterials, both on the cellular level and on that of tissues and organisms, with substantial overlap into the domain of nanotoxicology.


Mgr. Zbyněk Heger, PhD.

Head – Research group for molecular biology and nanomedicine
Assistant Professor

Phone: +420 545 133 285
Address: ÚCB AF, Zemědělská 1, 61300 Brno – Building D
Office: BA02N2004
Researcher ID: D-1973-2013
ORCID: 0000-0002-3915-7270

Team members

Topics of Ph.D. theses

  • Volné téma – v případě zájmu kontaktujte vedoucího výzkumné skupiny
  • Studium mikrobiomu u zdravých a mastitidních krav
  • Optional topic
  • Volné téma – imobilizace enzymů
  • Mechanismus vzniku bakteriální resistence k antimikrobiálním nanomateriálům
  • Vliv kovových a polokovových nanomateriálů na vznik bakteriální resistence
  • Nanomateriály a nové typy antimikrobiálních látek jako alternativa k antibiotickým preparátům


  • Strmiska, V.; Michalek, P.; Lackova, Z.; Guran, R.; Krizkova, S.; Vanickova, L.; Zitka, O.; Stiborova, M.; Eckschlager, T.; Klejdus, B.; Pacik, D.; Tvrdikova, E.; Keil, C.; Haase, H.; Adam, V.; Heger, Z.; Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe-Dnmts axis. Mol. Oncol. 2019, 13, 1002-1017. DOI: 10.1002/1878-0261.12439.
  • Khezri,; Mousavi, S. M. B.; Krej; Heger,; Sofer,; Pumera; Ultrafast Electrochemical Trigger Drug Delivery Mechanism for Nanographene Micromachines. Adv. Funct. Mater. 2019, 29, 1-10. DOI: 10.1002/adfm.201806696.
  • Bytesnikova, Z.; Richtera, L.; Smerkova, K.; Adam, V.; The graphene oxide as a tool for antibiotic resistance genes removal: A review. Environ. Sci. Pollut. Res. 2019, 26, 20148-20163. DOI: 10.1007/s11356-019-05283-y.
  • Skubalova, Z.; Michalkova, H.; Michalek, P.; Strmiska, V.; Guran, R.; Merlos, M. A. R.; Castkova, K.; Hynek, D.; Pekarik, V.; Zitka, O.; Adam, V.; Heger, Z.; Prevalent anatase crystalline phase increases the cytotoxicity of biphasic titanium dioxide nanoparticles in mammalian cells. Colloid Surf. B-Biointerfaces 2019, 182, 1-10. DOI: 1.
  • Strmiska, V.; Michalek, P.; Eckschlager, T.; Stiborova, M.; Adam, V.; Krizkova, S.; Heger, Z.; Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine. Biochim. Biophys. Acta-Rev. Cancer 2019, 1871, 248-258. DOI: 10.1016/j.bbcan.2019.01.001.
  • Haddad, Y.; Adam, V.; Heger, Z.; Rotamer dynamics: analysis of rotamers in molecular dynamics simulations of proteins . Biophys. J. 2019, 116, 2062-2072. DOI: 10.1016/j.bpj.2019.04.017.
  • Vanickova, L.; Guran, R.; Kollar, S.; Emri, G.; Krizkova, S.; Do, T.; Heger, Z.; Zitka, O.; Adam, V.; Mass spectrometric imaging of cysteine rich proteins in human skin. Int. J. Biol. Macromol. 2019, 125, 270-277. DOI: 10.1016/j.ijbiomac.2018.11.272.
  • Tesarova, B.; Charousova, M.; Dostalova, S.; Bienko, A.; Kopel, P.; Kruszynski, R.; Hynek, D.; Michalek, P.; Eckschlager, T.; Stiborova, M.; Adam, V.; Heger, Z.; Folic acid-mediated re-shuttling of ferritin receptor specificity towards a selective delivery of highly cytotoxic nickel(II) coordination compounds. Int. J. Biol. Macromol. 2019, 126, 1099-1111. DOI: 10.1016/j.ijbiomac.2018.12.128.
  • Peskova, M.; Ilkovics, L.; Hynek, D.; Dostalova, S.; Sanchez-Carnerero; Remes, M.; Heger, Z.; Pekarik, V.; Detergent-modified catalytic and enzymomimetic activity of silver and palladium nanoparticles biotemplated by Pyrococcus furiosus ferritin. J. Colloid Interface Sci. 2019, 537, 20-27. DOI: 10.1016/j.jcis.2018.11.005.
  • Jelinkova, P.; Mazumdar, A.; Sur, V. P.; Kociova, S.; Dolezelikova, K.; Jimenez Jimenez, A. M.; Koudelkova, Z.; Mishra, P. K.; Smerkova, K.; Heger, Z.; Vaculovicova, M.; Moulick, A.; Adam, V.; Nanoparticle-drug conjugates treating bacterial infections. J. Control. Release 2019, 307, 166-185. DOI: 10.1016/j.jconrel.2019.06.013.
  • Buchtelova, H.; Skubalova, Z.; Strmiska, V.; Michalek, P.; Kociova, S.; Smerkova, K.; Kruszynski,; Bienko,; Kaj,; Lewinska,; Bienko,; Malik-Gajewska,; Milosavljevic,; Kopel,; Heger,; Adam, V.; Synthesis and structural characterization of antimicrobial binuclear copper (II) coordination compounds bridged by hydroxy- and/or thiodipropionic acid. J. Inorg. Biochem. 2019, 191, 8-20. DOI: 10.1016/j.jinorgbio.2018.10.011.
  • Ananbeh, H. A. A. A.; Stojanovic, M.; Pompeiano, A.; Voberkova, S.; Trasar-Cepeda, C.; Use of soil enzyme activities to assess the recovery of soil functions in abandoned coppice forest systems. Sci. Total Environ. 2019, in press, . DOI: 10.1016/j.scitotenv.2019.133692.
  • Jimenez Jimenez, A. M.; Moulick, A.; Bhowmick, S.; Strmiska, V.; Gagic, M.; Horakova, Z.; Kostrica, R.; Masarik, M.; Heger, Z.; Adam, V.; One-step detection of human papilloma viral infection using quantum dot-nucleotide interaction specificity. Talanta 2019, 205, 1-8. DOI: 10.1016/j.talanta.2019.07.006.
  • Indra, R.; Cerna, T.; Heger, Z.; Hrabeta, J.; Wilhelm, M.; Dostalova, S.; Lengalova, A.; Martinkova, M.; Adam, V.; Eckschlager, T.; Schmeiser, H. H.; Arlt, V. M.; Stiborova, M.; Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells. Toxicology 2019, 419, 40-54. DOI: 10.1016/j.tox.2019.03.009.
  • Milosavljevic, V.; Jamroz, E.; Gagic, M.; Haddad, Y.; Michalkova, H.; Balkova, R.; Tesarova, B.; Moulick, A.; Heger, Z.; Richtera, L.; Kopel, P.; Adam, V.; Encapsulation of Doxorubicin in Furcellaran/Chitosan Nanocapsules by Layer-by-Layer Technique for Selectively Controlled Drug Delivery. Biomacromolecules 2019, in press, . DOI: 10.1021/acs.biomac.9b01175 .
  • Gagic, M.; Jamroz, E.; Krizkova, S.; Milosavljevic, V.; Kopel, P.; Adam, V.; Current trends in detection of histamine in food and beverages . J. Agric. Food Chem. 2019, 67, 773-783. DOI: 10.1021/acs.jafc.8b05515.
  • Merlos, M. A. R.; Buchtelova, H.; de los Rios; Casal; Eckschlager, T.; Hrabeta, J.; Belhajova, M.; Heger, Z.; Adam, V.; Proteomic signature of neuroblastoma cells UKF-NB-4 reveals key role of lysosomal sequestration and the proteasome complex in acquiring chemoresistance to cisplatin. J. Proteome Res. 2019, 18, 1255-1263. DOI: 10.1021/acs.jproteome.8b00867 .
  • Beladi-Mousavi,; Khezri,; Krej; Heger,; Sofer,; Fisher,; Pumera; Recoverable Bismuth-Based Microrobots: Capture, Transport, and On-Demand Release of Heavy Metals and an Anticancer Drug in Confined Spaces . ACS Appl. Mater. Interfaces 2019, 11, 13359-13369. DOI: 10.1021/acsami.8b19408.
  • Horky, P.; Skalickova, S.; Urbankova, L.; Baholet, D.; Kociova, S.; Bytesnikova, Z.; Kabourkova, E.; Lackova, Z.; Cernei, N.; Gagic, M.; Milosavljevic, V.; Smolikova, V.; Vaclavkova, E.; Nevrkla, P.; Knot, P.; Krystofova, O.; Hynek, D.; Kopel, P.; Skladanka, J.; Adam, V.; Smerkova, K.; Zinc phosphate-based nanoparticles as a novel antibacterial agent: in vivo study on rats after dietary exposure. J. Anim. Sci. Biotechnol. 2019, 10, 1-12. DOI: 10.1186/s40104-019-0319-8.
  • Michalkova, H.; Strmiska, V.; Kudr, J.; Skubalova, Z.; Tesarova, B.; Svec, P.; Richtera, L.; Zitka, O.; Adam, V.; Heger, Z.; Tuning the surface coating of IONs towards efficient sonochemical tethering and sustained liberation of topoisomerase II poisons. Int. J. Nanomed. 2019, 14, 7609. DOI: 10.2147/IJN.S208810.